Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deathsPaul Bastard, Luisa Imberti, Alba Parra-Martínez et al.|Science Immunology|2021Cited by 638
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Proceedings of the National Academy of Sciences|2022Cited by 198
Autoantibodies against type I IFNs in patients with critical influenza pneumoniaQian Zhang, José Luis Barrera Franco, Andrés Pizzorno et al.|The Journal of Experimental Medicine|2022Cited by 133
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Research Square|2022Cited by 24
Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deathsPaul Bastard, Luisa Imberti, Adrian Gervais et al.|Science Immunology|2021Cited by 1